![Kumar Brahma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Kumar is a Vice President at Longitude Capital.
Prior to joining Longitude Capital in 2022, Dr. Kumar was an Engagement Manager at McKinsey & Co., where he focused on R&D strategy for biopharmaceutical clients.
Dr. Kumar currently serves as a board observer at Avenge Bio, Lexeo Therapeutics, and Opna Bio.
Dr. Kumar holds an MD and a PhD in Immunology from Columbia University, and a BA in Economics from Johns Hopkins University.
Postes actifs de Kumar Brahma
| Sociétés | Poste | Début |
|---|---|---|
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Private Equity Investor | 01/07/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Finance |
